12-Week Study on the Efficacy of Two Serums in Improving Skin Aging and Tone
12-Week Serum Efficacy Study
1 other identifier
interventional
120
1 country
1
Brief Summary
This study aims to evaluate the anti-aging and skin tone improvement effects of two facial serums over a 12-week period. It was conducted at a single research center with a 2-week washout period followed by full-face application of the test products for 12 weeks. A total of at least 120 healthy Chinese female participants aged 18 to 45 were enrolled and divided into two treatment groups:Each group included both early aging (18-29 years) and mature aging (30-45 years) subgroups, with at least 30 participants in each subgroup.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 22, 2024
CompletedFirst Submitted
Initial submission to the registry
August 20, 2025
CompletedFirst Posted
Study publicly available on registry
September 4, 2025
CompletedSeptember 8, 2025
September 1, 2025
3 months
August 20, 2025
September 4, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Change in Dermatologist-Assessed Wrinkle Attributes
Crow's feet wrinkles, forehead wrinkles, global wrinkles, small folds on nasolabial zone and global fine lines will be evaluated by dermatologist.
from Baseline to Week 12
Self-assessment Questionnaire
Participants will complete a 5-point self-assessment questionnaire at Timm, T4w, T8w, and T12w, evaluating their perception of skin softness, smoothness, plumpness, elasticity, hydration, oil control, and visible aging signs. Ratings from 4 to 5 will be used to calculate "Top 2 box" percentage.
12 weeks
Change in Dermatologist-Assessed Skin Texture and Quality Attributes
Skin smoothness (visual), skin elasticity, skin softness, skin firmness, skin plumpness, cheek pores will be evaluated by dermatologist.
from Baseline to Week 12
Change in Dermatologist-Assessed Skin Tone Attributes
Skin radiance, skin translucency, skin pigmentation, skin fairness, skin tone evenness and skin dullness will be evaluated by dermatologist.
from Baseline to Week 12
Secondary Outcomes (5)
Change in Skin Hydration Measured by Corneometer
12 weeks
Change in Skin Elasticity Measured by Cutometer
12 weeks
Change in Transepidermal Water Loss (TEWL) Measured by Vapometer
12 weeks
Change in Facial Image-Based Skin Parameters Using VISIA-CR
12 weeks
Change in Cheek Skin Surface Condition Using VisioScan VC20
12 weeks
Study Arms (2)
Serum 1 Group
EXPERIMENTALParticipants in this arm applied Serum 1 (Fla#897183 329) to the full face twice daily for 12 weeks. The group included both early aging (18-29 years) and mature aging (30-45 years) subgroups.
Serum 2 Group
EXPERIMENTALParticipants in this arm applied Serum 2 (Fla#b50198) to the full face twice daily for 12 weeks. The group included both early aging (18-29 years) and mature aging (30-45 years) subgroups.
Interventions
Applied topically on the full face in the morning and evening for 12 weeks during the treatment period. Used by participants in the Serum 1 group.
Applied topically on the full face in the morning and evening for 12 weeks during the treatment period. Used by participants in the Serum 2 group.
Eligibility Criteria
You may qualify if:
- Chinese female aged 18-45 years (evenly split among Early aging \[18-29 years\] and Mature aging \[30-45 years\]).
- All skin types (dry, normal, oily, or mixed).
- Currently experiencing lack of radiance, roughness, dullness, and fine lines or wrinkles on facial skin as self-claimed.
- Early aging group (18-29 years): Must present with corresponding severity for the attributes evaluated by Dermatologist, including:
- Skin smoothness, radiance, dullness: grade between 2 and 6 (scale 0-9);
- Size of acne marks (PIH): size ≥ 2;
- Small folds on nasolabial zone: grade between 1 and 3 (Skin Aging Atlas, 0-6 scale, Page 56-57).
- Mature aging group (30-45 years): Must present with corresponding severity for the attributes evaluated by Dermatologist, including:
- Skin smoothness, radiance, dullness: grade between 4 and 6 (scale 0-9);
- Small folds on nasolabial zone: grade between 1 and 4 (Skin Aging Atlas, 0-6 scale, Page 56-57);
- Forehead wrinkles: grade ≥ 2 (Skin Aging Atlas, 0-8 scale, Page 32-33);
- Crow's feet wrinkles: grade ≥ 2 (Skin Aging Atlas, 0-6 scale, Page 40-41).
- Regular user of serum and sunscreen products.
- Did not participate in any clinical test or cosmetic product test on skin within the last 3 months.
- In general good health at the time of the study.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ChinaNormlead
Study Sites (1)
Shanghai China-norm Quality Technical Service Co., Ltd., Shanghai, Shanghai 200072
Shanghai, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2025
First Posted
September 4, 2025
Study Start
November 18, 2023
Primary Completion
March 1, 2024
Study Completion
March 22, 2024
Last Updated
September 8, 2025
Record last verified: 2025-09